These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Distribution of lipid-based nanoparticles to infarcted myocardium with potential application for MRI-monitored drug delivery. Paulis LE, Geelen T, Kuhlmann MT, Coolen BF, Schäfers M, Nicolay K, Strijkers GJ. J Control Release; 2012 Sep 10; 162(2):276-85. PubMed ID: 22771978 [Abstract] [Full Text] [Related]
3. Contrast enhancement by lipid-based MRI contrast agents in mouse atherosclerotic plaques; a longitudinal study. den Adel B, van der Graaf LM, Que I, Strijkers GJ, Löwik CW, Poelmann RE, van der Weerd L. Contrast Media Mol Imaging; 2013 Sep 10; 8(1):63-71. PubMed ID: 23109394 [Abstract] [Full Text] [Related]
4. Multimodality imaging demonstrates trafficking of liposomes preferentially to ischemic myocardium. Lipinski MJ, Albelda MT, Frias JC, Anderson SA, Luger D, Westman PC, Escarcega RO, Hellinga DG, Waksman R, Arai AE, Epstein SE. Cardiovasc Revasc Med; 2016 Mar 10; 17(2):106-12. PubMed ID: 26874740 [Abstract] [Full Text] [Related]
5. Prolonged targeting of ischemic/reperfused myocardium by liposomal adenosine augments cardioprotection in rats. Takahama H, Minamino T, Asanuma H, Fujita M, Asai T, Wakeno M, Sasaki H, Kikuchi H, Hashimoto K, Oku N, Asakura M, Kim J, Takashima S, Komamura K, Sugimachi M, Mochizuki N, Kitakaze M. J Am Coll Cardiol; 2009 Feb 24; 53(8):709-17. PubMed ID: 19232905 [Abstract] [Full Text] [Related]
9. Effective inhibition of cardiomyocyte apoptosis through the combination of trimetazidine and N-acetylcysteine in a rat model of myocardial ischemia and reperfusion injury. Şentürk T, Çavun S, Avcı B, Yermezler A, Serdar Z, Savcı V. Atherosclerosis; 2014 Dec 24; 237(2):760-6. PubMed ID: 25463117 [Abstract] [Full Text] [Related]
10. Delivery of modified mRNA to damaged myocardium by systemic administration of lipid nanoparticles. Evers MJW, Du W, Yang Q, Kooijmans SAA, Vink A, van Steenbergen M, Vader P, de Jager SCA, Fuchs SA, Mastrobattista E, Sluijter JPG, Lei Z, Schiffelers R. J Control Release; 2022 Mar 24; 343():207-216. PubMed ID: 35077739 [Abstract] [Full Text] [Related]
11. Myocardial infarction quantification with late gadolinium-enhanced magnetic resonance imaging in rats using a 7-T scanner. Luo D, Yao YY, Li YF, Sheng ZL, Tang Y, Fang F, Fang K, Ma GS, Teng GJ. Cardiovasc Pathol; 2012 Mar 24; 21(2):112-9. PubMed ID: 21652224 [Abstract] [Full Text] [Related]
13. Regulatory T cells contribute to rosuvastatin-induced cardioprotection against ischemia-reperfusion injury. Ke D, Fang J, Fan L, Chen Z, Chen L. Coron Artery Dis; 2013 Jun 24; 24(4):334-41. PubMed ID: 23531479 [Abstract] [Full Text] [Related]
15. Manganese-Enhanced Magnetic Resonance Imaging Enables In Vivo Confirmation of Peri-Infarct Restoration Following Stem Cell Therapy in a Porcine Ischemia-Reperfusion Model. Dash R, Kim PJ, Matsuura Y, Ikeno F, Metzler S, Huang NF, Lyons JK, Nguyen PK, Ge X, Foo CW, McConnell MV, Wu JC, Yeung AC, Harnish P, Yang PC. J Am Heart Assoc; 2015 Jul 27; 4(7):. PubMed ID: 26215972 [Abstract] [Full Text] [Related]
16. Nanoparticle-Mediated Targeting of Cyclosporine A Enhances Cardioprotection Against Ischemia-Reperfusion Injury Through Inhibition of Mitochondrial Permeability Transition Pore Opening. Ikeda G, Matoba T, Nakano Y, Nagaoka K, Ishikita A, Nakano K, Funamoto D, Sunagawa K, Egashira K. Sci Rep; 2016 Feb 10; 6():20467. PubMed ID: 26861678 [Abstract] [Full Text] [Related]
17. BLT1 antagonist LSN2792613 reduces infarct size in a mouse model of myocardial ischaemia-reperfusion injury. de Hoog VC, Bovens SM, de Jager SC, van Middelaar BJ, van Duijvenvoorde A, Doevendans PA, Pasterkamp G, de Kleijn DP, Timmers L. Cardiovasc Res; 2015 Dec 01; 108(3):367-76. PubMed ID: 26449403 [Abstract] [Full Text] [Related]
18. Lipid-based nanoparticles for contrast-enhanced MRI and molecular imaging. Mulder WJ, Strijkers GJ, van Tilborg GA, Griffioen AW, Nicolay K. NMR Biomed; 2006 Feb 01; 19(1):142-64. PubMed ID: 16450332 [Abstract] [Full Text] [Related]
19. Treatment with OPN-305, a humanized anti-Toll-Like receptor-2 antibody, reduces myocardial ischemia/reperfusion injury in pigs. Arslan F, Houtgraaf JH, Keogh B, Kazemi K, de Jong R, McCormack WJ, O'Neill LA, McGuirk P, Timmers L, Smeets MB, Akeroyd L, Reilly M, Pasterkamp G, de Kleijn DP. Circ Cardiovasc Interv; 2012 Apr 01; 5(2):279-87. PubMed ID: 22354933 [Abstract] [Full Text] [Related]